Original AMC Clinical practice station · AMC-03 · Counselling and education

Type 2 diabetes review and a new medicine

2 minutes reading · 8 minutes with the patient. This station is part of the AMC Clinical pass (A$39 for 30 days). Try the free station first →

Candidate instructions · Management/Counselling/Education

Your task

You are a general practitioner. Mrs Leilani Fotu, aged 59, has had type 2 diabetes for nine years and is here for a review. She takes metformin, a statin and a blood pressure tablet. Recent results: HbA1c 8.9% (74 mmol/mol), eGFR 78 mL/min/1.73 m², urine albumin to creatinine ratio mildly raised, LDL cholesterol 3.1 mmol/L. You are considering adding empagliflozin. Review how she is managing, discuss her results and treatment options, assess whether empagliflozin is suitable and counsel her about it if recommended. Answer her questions. You may request examination findings from the examiner.

Points candidates often miss

  • Explore why doses are missed before changing treatment; side effects and shift work are common reasons.
  • Name the fear behind a refusal, here insulin, and address it directly.
  • Counsel on a new medicine with its purpose, how to take it, common effects and who to call.
  • Sick-day guidance and warning signs of ketoacidosis, which can occur with normal sugar readings, are a safety requirement with SGLT2 inhibitors.

How this practice station works

Speak to the AI patient as you would in the exam; the examiner gives findings you ask for in examination stations. At the end you get estimated feedback against this station's fixed checklist, in the AMC layout: key steps, domain ratings and a global rating. It is not an AMC result and does not predict whether you will pass.

Related stations

Original station written for practice, reviewed for clinical accuracy 16 November 2026. Exam format: AMC clinical examination.